Keywords: arpida, initiates, major, cost-cutting, program, swiss, drug

Arpida initiates major cost-cutting program

Article | 08 December 2008

Print This

Swiss drug developer Arpida says it has begun a "significant" cost-cutting program to focus resources on its lead product iclaprim, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in